MassMutual Private Wealth & Trust’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.7K Hold
568
﹤0.01% 1018
2026
Q1
$10.7K Hold
568
﹤0.01% 1340
2025
Q4
$7.61K Buy
568
+136
+31% +$1.68K ﹤0.01% 1502
2025
Q3
$5.09K Hold
432
﹤0.01% 1667
2025
Q2
$2.8K Sell
432
-135
-24% -$888 ﹤0.01% 1848
2025
Q1
$3.32K Buy
+567
New +$4.06K ﹤0.01% 1755

Other funds holding DFTX

MassMutual Private Wealth & Trust's DFTX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 568 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1018.

MassMutual Private Wealth & Trust first reported a position in DFTX in Q1 2025 and has held it in 6 quarters since. 17 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • MassMutual Private Wealth & Trust held 568 shares of Definium Therapeutics worth $26.7K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Definium Therapeutics share count unchanged in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1018 holding.
  • MassMutual Private Wealth & Trust first reported a position in Definium Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 17 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.